logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

East Rui Pharmaceutical (02348.HK) spent HKD 378,300 to repurchase 404,000 shares on October 28.

date
28/10/2026
Zhitong Finance APP News, Dawnrays Pharmaceutical (02348.HK) announced that on October 28, 2026, the company spent HK$378,300 to repurchase 404,000 shares at a repurchase price of HK$0.93-0.94 per share.
Latest
4 m ago
Board Chairman Liu Yanjun acquired a total of 263,300 shares of Baoji Pharmaceutical-B (02659.HK) over three days, involving approximately HK$2.0243 million.
4 m ago
Israel's election deadlock triggers a "triple sell-off in stocks, bonds, and currency" will it spread to global markets?
4 m ago
VSING (08292.HK): Elite Partners CPA Limited resigns as auditor
5 m ago
Kuang-Chi Technology (002625.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 319 million yuan, a year-on-year decrease of 47.33%.
5 m ago
Basecare Medical-B (02170.HK) repurchased 83,000 shares on October 28 for approximately HK$106,700.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.